95 related articles for article (PubMed ID: 3794810)
1. Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma.
Nelp WB; Eary JF; Jones RF; Hellstrom KE; Hellstrom I; Beaumier PL; Krohn KA
J Nucl Med; 1987 Jan; 28(1):34-41. PubMed ID: 3794810
[TBL] [Abstract][Full Text] [Related]
2. Lymphoscintigraphy in melanoma: initial evaluation of a low protein dose monoclonal antibody cocktail.
Wahl RL; Liebert M; Headington J; Wilson BS; Shulkin BL; Johnson JW; Mallette S; Natale RB; Coon W; East M
Cancer Res; 1990 Feb; 50(3 Suppl):941s-948s. PubMed ID: 2297746
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
Lotze MT; Carrasquillo JA; Weinstein JN; Bryant GJ; Perentesis P; Reynolds JC; Matis LA; Eger RR; Keenan AM; Hellström I
Ann Surg; 1986 Sep; 204(3):223-35. PubMed ID: 3753057
[TBL] [Abstract][Full Text] [Related]
4. Lymphoscintigraphy for malignant melanoma. Surgical considerations.
Reintgen DS; Sullivan D; Coleman E; Briner W; Croker BP; Seigler HF
Am Surg; 1983 Dec; 49(12):672-8. PubMed ID: 6546188
[TBL] [Abstract][Full Text] [Related]
5. Lymphoscintigraphy in patients with malignant melanoma: a quantitative and qualitative evaluation of its usefulness.
Bergqvist L; Strand SE; Hafström L; Jönsson PE
Eur J Nucl Med; 1984; 9(3):129-35. PubMed ID: 6714247
[TBL] [Abstract][Full Text] [Related]
6. Lymphoscintigraphy of human colorectal carcinoma metastases in athymic mice by use of radioiodinated B72.3 monoclonal antibody.
Shah SA; Gallagher BM; Sands H
J Natl Cancer Inst; 1987 Jun; 78(6):1069-77. PubMed ID: 3473248
[TBL] [Abstract][Full Text] [Related]
7. Axillary lymph node groups--the center in lymphatic drainage from the truncal skin in man. Clinical significance for management of malignant melanoma.
Munz DL; Altmeyer P; Sessler MJ; Hör G
Lymphology; 1982 Dec; 15(4):143-7. PubMed ID: 7162208
[TBL] [Abstract][Full Text] [Related]
8. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.
Larson SM; Carrasquillo JA; Krohn KA; Brown JP; McGuffin RW; Ferens JM; Graham MM; Hill LD; Beaumier PL; Hellström KE
J Clin Invest; 1983 Dec; 72(6):2101-14. PubMed ID: 6196380
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
[TBL] [Abstract][Full Text] [Related]
10. Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer.
Tjandra JJ; Russell IS; Collins JP; Andrews JT; Lichtenstein M; Binns D; McKenzie IF
Cancer Res; 1989 Mar; 49(6):1600-8. PubMed ID: 2647290
[TBL] [Abstract][Full Text] [Related]
11. [Scintigraphic studies of the lymph nodes in patients with melanoma following lymph node excision].
Török L; Károlyi Z; Mari B; Kádár L; Németh P
Z Hautkr; 1988 Oct; 63(10):822-7. PubMed ID: 3239131
[TBL] [Abstract][Full Text] [Related]
12. Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody.
Engelstad BL; Spitler LE; Del Rio MJ; Ramos EC; Rosendorf LL; Reinhold CE; Khentigan A; Huberty JP; Corpuz SW; Lee HM
Radiology; 1986 Nov; 161(2):419-22. PubMed ID: 3763912
[TBL] [Abstract][Full Text] [Related]
13. Utility of lymphoscintigraphy in directing surgical therapy for melanomas of the head, neck, and upper thorax.
Eberbach MA; Wahl RL; Argenta LC; Froelich J; Niederhuber JE
Surgery; 1987 Sep; 102(3):433-42. PubMed ID: 3629471
[TBL] [Abstract][Full Text] [Related]
14. Survival after groin dissection for malignant melanoma.
Karakousis CP; Emrich LJ; Driscoll DL; Rao U
Surgery; 1991 Feb; 109(2):119-26. PubMed ID: 1992543
[TBL] [Abstract][Full Text] [Related]
15. The expanding role of lymphoscintigraphy in the management of cutaneous melanoma. First Place Winner: Conrad Jobst award.
Norman J; Cruse W; Ruas E; Beatty E; Hymes S; Espinosa C; Clark R; Reintgen D
Am Surg; 1989 Dec; 55(12):689-94. PubMed ID: 2596765
[TBL] [Abstract][Full Text] [Related]
16. Lymphoscintigraphy in malignant melanoma: 99mTc antimony sulfur colloid.
Sullivan DC; Croker BP; Harris CC; Deery P; Seigler HF
AJR Am J Roentgenol; 1981 Oct; 137(4):847-51. PubMed ID: 6974983
[TBL] [Abstract][Full Text] [Related]
17. The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study.
Fee HJ; Robinson DS; Sample WF; Graham LS; Holmes EC; Morton DL
Surgery; 1978 Nov; 84(5):626-32. PubMed ID: 715678
[TBL] [Abstract][Full Text] [Related]
18. Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies.
Eary JF; Schroff RW; Abrams PG; Fritzberg AR; Morgan AC; Kasina S; Reno JM; Srinivasan A; Woodhouse CS; Wilbur DS
J Nucl Med; 1989 Jan; 30(1):25-32. PubMed ID: 2642954
[TBL] [Abstract][Full Text] [Related]
19. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node.
Uren RF; Howman-Giles RB; Shaw HM; Thompson JF; McCarthy WH
J Nucl Med; 1993 Sep; 34(9):1435-40. PubMed ID: 8355060
[TBL] [Abstract][Full Text] [Related]
20. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.
Allan CP; Hayes AJ; Thomas JM
ANZ J Surg; 2008 Nov; 78(11):982-6. PubMed ID: 18959697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
